N

Nurix Therapeutics

Drug discovery targeting ubiquitin E3 ligases

Director – IT Infrastructure & Operations

IT OperationsConfirmed live in the last 24 hours
Full-timeBrisbane, CA, USA$260k - $300k

About the Job

Requirements

  • At least 12 years of progressive technology services leadership, including at least 5 years at the Director or Senior Director level.
  • Direct experience leading infrastructure, cyber operations, and IT service management as one integrated scope.
  • Ability to partner with a CISO or fractional CISO on security policy while owning operational execution.
  • Deep experience across AWS, Microsoft Entra, and Microsoft 365.
  • Familiarity with infrastructure for scientific and machine-learning computing, including AWS ParallelCluster and high-performance computing, SageMaker, EKS, and ECS, as well as DevOps and infrastructure-as-code practices.
  • A measurable track record managing a managed service provider portfolio, including consolidation or vendor transitions with accountability for outcomes.
  • Experience building infrastructure in fast-moving, resource-constrained environments.
  • Experience in a regulated industry such as biotech, pharma, medical device, healthcare, financial services, or a comparable industry.
  • Bachelor’s degree or equivalent practical experience.

Responsibilities

  • Lead IT infrastructure, cybersecurity operations, end-user services, and IT service management as one integrated function, reporting to the SVP of Information Technology.
  • Own the IT infrastructure and operations function end to end, including infrastructure, cybersecurity operations, end-user services, and IT service management.
  • Partner with a fractional CISO on security strategy and policy while owning operational execution.
  • Work closely with IT business partner leaders who own application portfolios and partner directly with R&D and the broader scientific organization on infrastructure needs.
  • Lead a team spanning enterprise architecture, system administration, and cybersecurity operations, with the service desk delivered through staff and managed service providers.
  • Manage individual contributors and managers, set standards, and delegate delivery across internal staff and managed service providers.
  • Consolidate the managed service provider portfolio across infrastructure, security, and the help desk into a smaller, more accountable set of partners.
  • Build a cybersecurity operations function from existing contractor and managed detection and response coverage.
  • Establish a governance model with research and scientific computing and bring research infrastructure into IT alignment.
  • Work with the enterprise architect to inventory and remediate AWS systems, including ParallelCluster and other high-performance computing, container platforms such as EKS and ECS, SageMaker, and identity bridges.
  • Own a formal identity and access management program, including clean handoffs to IT operations and business partner teams.
  • Refresh the service experience end to end and raise vendor management discipline as scope grows.

Desired Qualifications

  • Biotech or pharmaceutical industry experience.
  • Support for an FDA Pre-Approval Inspection or BIMO inspection in an IT or security capacity.
  • Experience standing up a security operations function from contractor or managed service provider coverage.
  • Partnership with a separate scientific computing organization, such as informatics, bioinformatics, cheminformatics, or machine learning.
  • Hands-on experience with a managed detection and response provider such as RedCanary, Kroll, or Arctic Wolf.
  • Experience using Jira Service Management or ServiceNow at scale.
  • Public company SOX IT general controls experience.

About the Company

Nurix Therapeutics

Drug discovery targeting ubiquitin E3 ligases

Nurix Therapeutics develops drugs that use the body's own protein-degradation system to treat diseases. Its core approach is to control ubiquitin E3 ligases, enzymes that tag unwanted proteins for breakdown in cells. By modulating these ligases, Nurix aims to create therapeutics, especially small-molecule immuno-oncology agents, that can selectively remove disease-related proteins in cancer and other serious conditions. The company operates by discovering and developing drug candidates and earning revenue through partnerships, licensing, and potential future sales of its medicines. Unlike many biotech firms that target single proteins, Nurix focuses on the protein-degradation pathway to influence multiple disease processes through carefully designed molecules. The goal is to bring new cancer treatments and other therapies to patients by advancing its degrader-based drugs through research, collaboration, and development toward commercial use.

Company size
201-500
Company stage
IPO
Headquarters
Brisbane, CA
Founded
2012

Recently Posted Jobs

Explore more opportunities at Nurix Therapeutics

See more jobs